You are here


Director of the Maria Skłodowska-Curie
National Research Institute of Oncology
Gliwice Branch
Sławomir Blamek, M.D., Ph.D.

Sławomir Blamek is a specialist in oncological radiation therapy, the author and co-author of many articles published in Polish and international scientific journals, the author of radiation treatment guidelines used in clinical practice and a reviewer of scientific papers in Polish and foreign scientific journals (including New England Journal of Medicine, Neurosurgery, Neuroradiology, Neurosurgical Review, Child’s Nervous System, Radiation Oncology, Radiology and Oncology, Diabetes Research and Clinical Practice, European Journal of Paediatric Neurology, Frontiers in Oncology).
Member of many Polish and foreign scientific societies, including the International Brain Research Organization (IBRO), the Polish Society of Radiation Oncology (PTRO), the Polish Lymphoma Research Group (PGBCh), the Society of Innovative Technologies for Health, the International Lymphoma Radiation Oncology Group (ILROG) and the Polish Artificial Intelligence in Medicine Association.

The new director of NRIO Gliwice graduated from the Faculty of Medicine with the Department of Medicine and Dentistry in Zabrze of the Medical University of Silesia (then the Medical University of Silesia) in Katowice with excellent results and in 2001 obtained the title of doctor with distinction.
From the beginning of his professional career he worked intensively in research and in 2008 he obtained a PhD in medical sciences based on the dissertation "Evaluation of the results of treatment of cerebral arteriovenous hemangiomas using stereotactic radiosurgery". In the same year, he also obtained the title of specialist in oncological radiation therapy. In January 2015 he obtained a habilitation in medical sciences from the Oncology Center - Institute. Maria Skłodowska Curie in Warsaw. In 2023 he completed his MBA studies (Health Care profile) at the Silesian University of Technology in Gliwice with very good results (the partner university in the MBA program of the Silesian University of Technology is Nyenrode Business Universiteit in the Netherlands).

In the area of numerous scientific interests of prof. Sławomir Blamek's topics include: effectiveness and tolerability of radiotherapy and stereotactic radiosurgery for brain tumors and non-cancerous lesions of the central nervous system, extracranial stereotactic radiosurgery, modern radiotherapy techniques, technical and physical aspects of stereotactic radiosurgery, genetics and epigenetics of cancer, intraoperative radiotherapy, radiotherapy of metastases and risk factors for their formation.

In recent years he has been involved in research at the intersection of cardiology and oncology, including research on the sensitivity of implantable cardiac devices to ionizing radiation and co-creating national recommendations for the management of patients after implantation of such devices in radiotherapy. He also conducts research on the use of stereotactic radiotherapy in the treatment of patients with ventricular tachycardia resistant to other types of treatment. He is the principal investigator in the completed SMART-VT trial and the ongoing SMARTR-VT trial dedicated to the treatment of ventricular tachycardias. He is also the leader of the working group in the international STOPSTORM consortium, which maintains a register of patients undergoing radiotherapy for ventricular tachycardia.
As part of his interests in innovative treatment techniques, he initiated a study with the acronym INTROSPECTION aimed at examining the possibility of combining an advanced radiotherapy technique - radiotherapy with spatial dose differentiation - with immunotherapy in patients with advanced forms of cancer and using to assess the effect of this combination of innovative\e diagnostic methods - immuno- PET and proteomic studies.


Deputy Director
for Clinical Matters
Prof. Sebastian Giebel, M.D., Ph.D.

An internal medicine and hematology and clinical transplantation specialist, Prof. Giebel graduated from the Medical University of Silesia in Katowice, Faculty of Medicine in 1996. In 2003, he obtained the degree of a Doctor of Medical Sciences, followed by the title of Assistant Professor of Medical Sciences in 2008 and the title of the Professor in 2013. Since 2008, he has been working for the Cancer Centre in Gliwice, from 2011 he has been Head of the Department of Bone Marrow Transplantation and Hematology-Oncology and from 2015  the Deputy Director for Clinical Matters. Prof. Giebel is the President of Polish Adult Leukemia Group (PALG) and Polish Lymphoma Research Group (PLRG), the Secretary of the Working Group of Acute Leukemias of European Society for Blood and Marrow Transplantation (EBMT). An author of 120 scientific papers, mainly in the field of hematology and hematopoietic cell transplantation.

Deputy Director
for Outpatient Health Care and Diagnostic
Prof. Barbara Bobek-Billewicz, M.D., Ph.D.
Graduate of the Medical Department of the Medical Academy in Kraków (1980). She was granted the I degree (1983) and the II degree (1990) of the specialization in radiodiagnostics and since 2011 she has specialized in nuclear medicine. She was granted the Ph.D. in 1989 and the habilitation in 2001. In 2013 she was granted the title of Professor. She has been employed in the Oncology Center in Gliwice as the Head of the Department of Radiology and Image Diagnostics since 2004.
In terms of 2008-2012 and 2016-2021 she has been a member  of the Science Board of the Oncology Centre – Maria Skłodowska-Curie Memorial Institute and between 2008-2012 she was a Vice-chairwoman of the Committee for Ph.D. Conferment Procedure of the Science Board. Since May 2016 she has been working as the Deputy Director  for Outpatient Health Care and Diagnostic. In June 2016 she completed a postgraduate course in the field of Health Care Management at the Faculty of Health Sciences of the Jagiellonian University in Kraków.

Deputy Director
for Finances and Management
Anna Kotuła, M.A.
A graduate of the Wrocław University of Economics Faculty of Business Management and Information Technology (1999), she completed her post-graduate studies in management of health care institutions at the Katowice School of Economics in 2003 and in new quality management in health care at the College of Labor Safety Management in Katowice (2013).  She attended a number of professional training seminars dealing with the operation, organization and management of medical institutions.  Since 2006, she has been working as Deputy Director for Finance and Management.

Deputy Director
for Administration and Technical Matters

Zdzisław Tarasiewicz, M.A.
Graduate of the Department of Trade, Transport and Services at Karol Adamiecki Memorial Economic Academy in Katowice (1983). He participated in numerous trainings in the fields of public finances, organization and realization of public procurement, and business management. He possesses vast experience in managing various businesses of different ownership structures (public, private, collective, capital companies and partnerships) in the following industries: constructions, telecommunications and multimedia, energetics, health care, and social services.
He was employed in the Institute of Oncology in January 2017 as the Proxy for Development and since January 2018 he has been working as the Deputy Director for Administration and Technical Matters of the Maria Skłodowska-Curie Memorial Oncology Centre-Institute, branch in Gliwice.
Deputy Director for Scientific Matters
Tomasz Rutkowski, M.D., Ph.D.

Specialist in oncological radiotherapy and clinical oncology. Graduate of the Faculty of Medicine of the Medical University of Silesia in Zabrze (1997). He received his Ph.D. of Medical Sciences in 2004, post-doctoral degree in 2014. Employed at the Oncology Center in Gliwice since 1997. Employee of the Ist Department of Radiotherapy and Chemotherapy. Secretary of the Polish Society of Oncological Radiotherapy (2012-2017), member of the Scientific Council of the Institute of Oncology (2016-2017 and 2017-2020). Author of over 40 scientific publications, mainly on the treatment of cancer patients within the head and neck area.